So, do you believe the trial will meet at least OS targets?
I do not deny that OS results could be good.
If it was not for my total distrust for management, and the financials, I might even take a flyer on them. Particularly if I had the chance to do so after whatever the hell happened to PFS is disclosed.
I will not go as far as saying I believe they will be good though. Always too many unknowns to trust models. BTW, on that subject, Leprecon has done by far the best work in these parts.